A detailed history of Truist Financial Corp transactions in Organon & Co. stock. As of the latest transaction made, Truist Financial Corp holds 15,410 shares of OGN stock, worth $252,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,410
Previous 17,063 9.69%
Holding current value
$252,878
Previous $353,000 16.71%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $30,828 - $38,068
-1,653 Reduced 9.69%
15,410 $294,000
Q2 2024

Aug 20, 2024

SELL
$17.45 - $21.96 $32,683 - $41,131
-1,873 Reduced 9.89%
17,063 $353,000
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $55,519 - $75,745
-4,029 Reduced 17.54%
18,936 $355,000
Q4 2023

Feb 02, 2024

SELL
$10.95 - $17.32 $2,069 - $3,273
-189 Reduced 0.82%
22,965 $331,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $300,478 - $430,522
-18,112 Reduced 43.89%
23,154 $401,000
Q2 2023

Aug 01, 2023

BUY
$19.27 - $24.63 $100,531 - $128,494
5,217 Added 14.47%
41,266 $858,000
Q1 2023

May 05, 2023

SELL
$21.42 - $32.08 $181,341 - $271,589
-8,466 Reduced 19.02%
36,049 $847,000
Q4 2022

Feb 17, 2023

SELL
$23.31 - $28.61 $340,559 - $417,992
-14,610 Reduced 24.71%
44,515 $1.24 Million
Q3 2022

Oct 26, 2022

SELL
$23.4 - $34.25 $338,878 - $496,008
-14,482 Reduced 19.67%
59,125 $1.38 Million
Q2 2022

Jul 22, 2022

SELL
$31.66 - $38.9 $1.03 Million - $1.26 Million
-32,397 Reduced 30.56%
73,607 $2.48 Million
Q1 2022

Apr 22, 2022

BUY
$30.45 - $39.36 $997,389 - $1.29 Million
32,755 Added 44.72%
106,004 $3.7 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $857,003 - $1.11 Million
-29,892 Reduced 28.98%
73,249 $2.23 Million
Q3 2021

Nov 05, 2021

SELL
$28.63 - $35.64 $7 Million - $8.71 Million
-244,483 Reduced 70.33%
103,141 $3.38 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $9.89 Million - $13.2 Million
347,624 New
347,624 $10.5 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.17B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.